Calendar Ironwood Pharmaceuticals, Inc.

Equities

IRWD

US46333X1081

Real-time Estimate Cboe BZX 09:39:13 2024-04-19 am EDT 5-day change 1st Jan Change
7.715 USD +1.65% Intraday chart for Ironwood Pharmaceuticals, Inc. -5.24% -33.65%

Chart calendar Ironwood Pharmaceuticals, Inc.

bb7bf35fc6fef9a6.rx1KLTcRdj1HRki_wlGvdgV8Qzsujvsxz2iX1JJEu1s.2i8aS0FYWwoyGS3Z9nzgJG8uIFpXzKJu_ljFo94V5GnjMC5AdHMxdSgSJw~be37049fa420637926cfa5f5b1f2ca19

Upcoming events on Ironwood Pharmaceuticals, Inc.

2024-05-01 Q1 2024 Earnings Release (Projected)
2024-05-13 RBC Capital Markets Global Healthcare Conference
2024-07-31 Q2 2024 Earnings Release (Projected)
2024-10-30 Q3 2024 Earnings Release (Projected)
2025-02-12 Q4 2024 Earnings Release (Projected)

Past events on Ironwood Pharmaceuticals, Inc.

2024-03-03 02:00 pm American Society for Parenteral and Enteral Nutrition Science and Practice Conference
2024-03-03 12:45 pm American Society for Parenteral and Enteral Nutrition Science and Practice Conference - Long-Acting
2024-03-03 12:45 pm American Society for Parenteral and Enteral Nutrition Science and Practice Conference - Dr. Dejan Mi
2024-03-03 12:45 pm American Society for Parenteral and Enteral Nutrition Science and Practice Conference - Short Bowel
2024-03-03 12:45 pm American Society for Parenteral and Enteral Nutrition Science and Practice Conference - Pharmacokine
2024-02-29 08:00 am Apraglutide Phase 3 Clinical Trial Results Call
2024-02-15 08:30 am Q4 2023 Earnings Call
2024-02-15 07:00 am Q4 2023 Earnings Release
2024-01-10 02:15 pm JPMorgan Healthcare Conference
2023-11-29 09:00 am Piper Sandler Healthcare Conference
2023-11-09 08:30 am Q3 2023 Earnings Call
2023-11-09 07:00 am Q3 2023 Earnings Release
2023-10-07 03:30 pm North American Society for Pediatric Gastroenterology, Hepatology & Nutrition Meeting - Presentation
2023-10-07 03:30 pm North American Society for Pediatric Gastroenterology, Hepatology & Nutrition Meeting - Presentation
2023-10-06 03:30 pm North American Society for Pediatric Gastroenterology, Hepatology & Nutrition Meeting - Presentation
2023-08-08 08:30 am Q2 2023 Earnings Call
2023-08-08 07:00 am Q2 2023 Earnings Release
2023-06-19 Annual General Meeting
2023-05-22 08:30 am Acquisition of VectivBio Holding AG by Ironwood Pharmaceuticals, Inc Call
2023-05-16 01:30 pm JMP Securities Life Sciences Conference - Fireside Chat

Past dividends on Ironwood Pharmaceuticals, Inc.

2019-04-01 0

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
428
416
3.1%
390
381
2.36%
414
407
1.57%
411
411
-0.2%
443
443
-0.03%

448

EBITDA
Million USD
Released
Forecast
Spread
148
105
40.85%
161
146
10.23%
234
246
-5.04%
252
250
0.67%
-885
192
-560.24%

157

EBIT
Million USD
Released
Forecast
Spread
120
97,8
22.87%
143
149
-3.82%
232
241
-3.5%
250
249
0.67%
-945
-384
-146.32%

153

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
21,5
16,6
29.43%
109
114
-4.51%
201
208
-3.31%
252
247
2.33%
-948
-951
0.28%

129

Net income
Million USD
Released
Forecast
Spread
21,5
17,0
26.81%
106
112
-5.03%
528
540
-2.1%
175
174
0.75%
-1 002
-967
-3.61%

106

EPS
USD
Released
Forecast
Spread
0,14
0,13
6.14%
0,66
0,68
-2.58%
3,21
3,26
-1.4%
0,96
0,94
1.77%
-6,45
-6,38
-1.1%

0,78

Announcement Date13/02/2017/02/2117/02/2216/02/2315/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
117
110
6.31%
97,5
96,6
0.94%
97,2
104
-6.07%
109
110
-1.6%
107
108
-0.95%
104
101
3.44%
107
104
3.54%
114
113
0.82%
118
117
0.13%

106


112


115


114


110

EBITDA
Million USD
Released
Forecast
Spread
57,0





56,0
67,5
-17.01%
68,8
67,8
1.59%
68,7
68,0
1.03%
60,4
59,0
2.34%
-1 034
60,4
-1812.39%
49,1
23,0
113.06%
39,9
45,7
-12.7%

32,2


37,3


40,2


39,0


37,0

EBIT
Million USD
Released
Forecast
Spread
56,6
63,9
-11.44%
57,8
51,0
13.48%
55,7
61,9
-10.04%
68,5
67,6
1.36%
68,4
66,6
2.61%
60,1
59,4
1.23%
20,3
59,4
-65.79%
40,0
34,8
14.93%
37,6
43,7
-13.89%

31,5


41,6


40,6


41,8


36,9

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
46,3


56,5
46,5
21.56%
53,8
57,7
-6.84%
69,9
66,8
4.68%
72,3
66,9
8.02%
65,9
62,0
6.17%
-1 076
62,1
-1834.28%
31,9
35,9
-11.13%
30,4
34,9
-13.01%

27,4


36,8


34,8


38,9


27,6

Net income
Million USD
Released
Forecast
Spread
41,4


38,8
44,1
-11.92%
37,1
55,9
-33.61%
50,3
48,1
4.55%
48,9
47,8
2.16%
45,7
44,5
2.73%
-1 062
44,2
-2502.3%
15,3
23,5
-34.91%
-1,09
36,4
-102.99%

27,9


31,5


28,9


33,5


22,1

EPS
USD
Released
Forecast
Spread
0,25
0,28
-11.4%
0,21
0,30
-29.44%
0,21
0,31
-32.67%
0,28
0,31
-9.5%
0,27
0,26
3.48%
0,25
0,24
2.74%
-6,84
0,25
-2872.94%
0,09
0,16
-42.86%
-0,01
0,16
-106.12%

0,20


0,22


0,18


0,23


0,14

Announcement Date17/02/2205/05/2204/08/2203/11/2216/02/2304/05/2308/08/2309/11/2315/02/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. IRWD Stock
  4. Calendar Ironwood Pharmaceuticals, Inc.